Drugs & Targets University of Florida Health, Nuance Communications form collaboration focused on AI in radiology April 14, 2023Vol.49 No.15
Conversation with The Cancer Letter Gary Schwartz talks about his vision for Case CCC, leaving New York, his illustrious father—and Isaac Asimov April 07, 2023Vol.49 No.14By Paul Goldberg
NCI NCI Director Bertagnolli designs Cancer Plan to trigger national conversation, transform cancer research and care April 07, 2023Vol.49 No.14By Matthew Bin Han Ong
“Historic” cisplatin shortage leaves oncologists guessing whether they will have enough to treat the next patient April 07, 2023Vol.49 No.14By Jacquelyn Cobb
Guest Editorial Leading a matrix cancer center: Extensive responsibility, modest influence, little authority April 07, 2023Vol.49 No.14By George J. Weiner
In Brief NCAB Chair John D. Carpten named director and chief scientific officer of City of Hope, director of Beckman Research Institute April 07, 2023Vol.49 No.14
In Brief Phyllis Pettit Nassi and Jane Perlmutter to receive AACR 2023 Distinguished Public Service Award April 07, 2023Vol.49 No.14
In Brief Ericka Bennett, Petrina Hill-Cheatom, Anthony Putrelo appointed to executive roles at Roswell Park April 07, 2023Vol.49 No.14
